Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release — FDA Drug Shortage
The FDA lists a drug shortage record for Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release (tablet) from Mylan Pharmaceuticals Inc., a Viatris Company with status To Be Discontinued. The shortage was first posted on 01/12/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Mylan Pharmaceuticals Inc., a Viatris Company
- Package NDC
- 0378-4615-01
- Dosage Form
- Tablet
- Presentation
- Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)
- Initial Posting
- 01/12/2026
- Revised Date